Floatz logo

Ifetroban

Cardiomyopathy, Dilated

Cumberland PharmaceuticalsSmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Cardiomyopathy, Dilated cohort.

Asset / SponsorPhaseRating
Bisoprolol Fumarate
Peking Union Medical College Hospital
Phase 2/3B

Same molecule, other indications

Ifetroban is also rated in:

Duchenne muscular dystrophyDormant
B
Indicative ·
57 / 100
View asset →
portal hypertensionDormant
B
Indicative ·
57 / 100
View asset →
cirrhosis of liverDormant
CCC
Indicative ·
54 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →